Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial tags : Approval save search
Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.502 -1.57% -1.59% 49K
|
Manufacturing
|
| O: 3.23%
H: 0.16%
C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study
ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator™ VAR 200 in Patients with Diabetic Kidney Disease
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
ZVSA | $0.581 -7.19% -7.75% 280K
|
|
| O: 7.64%
H: 21.41%
C: 1.07%
disease kidney cholesterol approval trial therapeutics diabetic
NeuroBo Pharmaceuticals Receives Safety Review Committee Approval to Continue With Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
Published: 2024-03-13 (Crawled : 12:00) - prnewswire.com
NRBO | $3.325 -3.34% -3.46% 21K
|
Health Technology
|
| O: 3.49%
H: 0.2%
C: -11.31%
da-1241 approval review treatment pharmaceuticals trial
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: 1.56%
H: 3.55%
C: 0.81%
precision approval arcus program trial
PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
PEPG | $10.59 -10.6% -11.85% 120K
|
|
| O: 0.06%
H: 4.93%
C: 4.03%
edo51 approval treatment clearance trial potential duchenne
NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published: 2024-02-29 (Crawled : 13:00) - prnewswire.com
NRBO | $3.325 -3.34% -3.46% 21K
|
Health Technology
|
| O: 9.32%
H: 6.66%
C: 3.45%
da-1726 obesity first approval treatment pharmaceuticals trial
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Published: 2024-02-26 (Crawled : 00:00) - biospace.com/
KZR | $0.7875 -0.01% -0.01% 420K
|
Health Technology
|
| O: 1.09%
H: 3.74%
C: -1.52%
lupus life approval sciences trial china
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
Published: 2024-02-23 (Crawled : 12:00) - globenewswire.com
CMND | $1.22 3.56% 3.43% 110K
|
n/a
|
| O: 2.15%
H: 0.0%
C: -1.05%
cmnd-100 alcohol approval trial
Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024
Published: 2024-02-14 (Crawled : 13:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 5.61%
H: 3.54%
C: 3.54%
fda fibromyalgia approval positive pharmaceuticals trial
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
Published: 2024-02-05 (Crawled : 12:30) - globenewswire.com
MBOT | $0.8701 -2.24% -2.29% 93K
|
Health Technology
|
| O: 1.65%
H: 1.63%
C: 0.81%
fda approval medical application trial
New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval
Published: 2024-02-01 (Crawled : 21:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 2.78%
H: 6.05%
C: 4.59%
fda fibromyalgia approval hope trial results
Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
Published: 2024-01-18 (Crawled : 00:00) - biospace.com/
HOTH | $1.22 3.39% 3.28% 22K
|
Health Technology
|
| O: 5.43%
H: 13.24%
C: 0.74%
ht-001 fda approval treat trial therapeutics
Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
Published: 2024-01-17 (Crawled : 12:30) - globenewswire.com
IXHL | $2.39 0.42% 0.42% 14K
|
Manufacturing
|
| O: 7.19%
H: 0.0%
C: -6.29%
ihl-42 drug approval ihl-42x trial
Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
SHPH | $0.409 1.89% 1.86% 12K
|
|
| O: 4.42%
H: 0.0%
C: -16.11%
fda approval treatment pharmaceuticals trial glioblastoma
Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE
Published: 2023-12-13 (Crawled : 14:30) - biospace.com/
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: 0.34%
H: 4.84%
C: 2.33%
first approval arcus application program trial
IntelGenx Receives Approval to Conduct ’MONTPARK’ Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease
Published: 2023-11-14 (Crawled : 12:30) - globenewswire.com
IGXT | $0.17 -19.77% 73K
|
Manufacturing
|
| O: 7.74%
H: 1.85%
C: -0.96%
versafilm disease parkinson's approval montelukast trial phase 2
MustGrow Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program
Published: 2023-11-07 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
approval trials program
SAB Biotherapeutics Receives Australian Approval to Commence Phase 1 Clinical Trial of SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes
Published: 2023-10-19 (Crawled : 12:00) - globenewswire.com
SABS | $4.46 0.22% 890
|
|
| O: 11.2%
H: 15.94%
C: 15.58%
sab-142 approval treatment trial diabetes potential
INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program
Published: 2023-10-10 (Crawled : 12:30) - inovio.com
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 13.73%
H: 45.31%
C: 23.98%
ino-3107 fda approval program trial
INmune Bio Inc. Announces Approval of Clinical Trial Application by the U.K. Medicines and Healthcare Products Regulatory Agency for Phase 2 Clinical Trial in Alzheimer’s Disease
Published: 2023-09-05 (Crawled : 12:00) - globenewswire.com
INMB | $8.33 -5.34% -5.64% 69K
|
Health Technology
|
| O: 6.88%
H: 0.0%
C: -8.4%
disease approval alzheimer’s application trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.